What is it about?
Pulmonary hypertension is a disease characterized by high blood pressure in the lung arteries. In sickle cell disease patients, pulmonary hypertension is associated with shortened lifespan and greater need for hospitalization. We now show for the first time that pulmonary hypertension is a particularly high risk clinical finding among hospitalized sickle cell disease patients. This reports identifies a need to develop strategies for improving outcome, including survival and length of hospitalization in this vulnerable patient population.
Featured Image
Read the Original
This page is a summary of: Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Patients with Sickle Cell Disease, American Review of Respiratory Disease, August 2018, American Thoracic Society,
DOI: 10.1164/rccm.201802-0261le.
You can read the full text:
Contributors
The following have contributed to this page







